Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Nuvectis Pharma, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 250 shares @ $11.27, valued at $2.8k
Bought 830 shares @ $11.19, valued at $9.3k
10/06/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 1,820 shares @ $10.95, valued at $19.9k
Bought 1,400 shares @ $11.09, valued at $15.5k
08/16/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 235 shares @ $14.34, valued at $3.4k
Bought 115 shares @ $15.15, valued at $1.7k
08/11/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 120 shares @ $14.83, valued at $1.8k
Bought 180 shares @ $14.66, valued at $2.6k
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2023 4 Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 1,556 shares @ $13.98, valued at $21.8k
07/27/2023 4 Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 10,000 shares @ $13.97, valued at $139.7k
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 110 shares @ $16.19, valued at $1.8k
Bought 150 shares @ $15.03, valued at $2.3k
07/13/2023 4 Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 3,285 shares @ $15.09, valued at $49.6k
07/12/2023 4 Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 10,000 shares @ $15.36, valued at $153.6k
07/10/2023 4 Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 8,948 shares @ $15.19, valued at $135.9k
07/07/2023 4 Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 3,179 shares @ $15.01, valued at $47.7k
07/07/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 320 shares @ $14.88, valued at $4.8k
07/06/2023 4 Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 1,176 shares @ $15.52, valued at $18.3k
06/16/2023 4 Mosseri Marlio Charles (10% Owner) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 400 shares @ $17.54, valued at $7k
Bought 31,724 shares @ $17.71, valued at $561.8k
06/08/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 230 shares @ $17.41, valued at $4k
Bought 120 shares @ $17.53, valued at $2.1k
06/01/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 330 shares @ $17.28, valued at $5.7k
05/26/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 200 shares @ $17.49, valued at $3.5k
05/18/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 320 shares @ $17.025, valued at $5.4k
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 230 shares @ $12.13, valued at $2.8k
03/23/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 480 shares @ $12.08, valued at $5.8k
03/22/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2023 4 Shemesh Shay (Chief Dev. & Ops. Officer) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 670 shares @ $10.71, valued at $7.2k
03/16/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Bought 1,680 shares @ $10.85, valued at $18.2k
Bought 480 shares @ $10.91, valued at $5.2k
01/13/2023 4 Poradosu Enrique (Chief Science & Business Off) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Granted 115,000 shares @ $0
01/13/2023 4 BENTSUR RON (Chairman & CEO) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Granted 210,000 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy